News

Positive Preclinical Results Unveiled for DPH001

We’re delighted to share positive results from our recent preclini...

Disruptive Pharma announces DPH001 pipeline project

We are excited to announce that Disruptive Pharma is initiating the deve...

Welcome Holger Müller – Director of Business Development at Disruptive Pharma

Holger brings more than 20 years of experience in commercialization of p...

Welcome Malin Vågerö – Director R&D at Disruptive Pharma

As an excellent addition to team Disruptive Pharma we are now happy to a...

Disruptive Pharma raises 41 million SEK to develop pipeline project towards clinical stage

We have some exciting news to share just before the summer – Disruptive ...